126 related articles for article (PubMed ID: 6736371)
1. Computed tomography in recurrent or metastatic colon cancer: relation to rising serum carcinoembryonic antigen.
Shirkhoda A; Staab EV; Bunce LA; Herbst CA; McCartney WH
J Comput Assist Tomogr; 1984 Aug; 8(4):704-8. PubMed ID: 6736371
[TBL] [Abstract][Full Text] [Related]
2. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
[TBL] [Abstract][Full Text] [Related]
3. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
Doerr RJ; Herrera L; Abdel-Nabi H
Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
[TBL] [Abstract][Full Text] [Related]
4. Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making?
Staib L; Schirrmeister H; Reske SN; Beger HG
Am J Surg; 2000 Jul; 180(1):1-5. PubMed ID: 11036130
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
Lunde OC; Havig O
Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
[TBL] [Abstract][Full Text] [Related]
6. [PET detection of recurring rectal adenocarcinoma in an unusual location. Case report].
Manrique I; Sastre J; Gómez A; Carreras JL; Peinador A; Díaz-Rubio E
Gastroenterol Hepatol; 2000 Apr; 23(4):181-5. PubMed ID: 10863860
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA.
Gade M; Kubik M; Fisker RV; Thorlacius-Ussing O; Petersen LJ
Cancer Imaging; 2015 Aug; 15(1):11. PubMed ID: 26263901
[TBL] [Abstract][Full Text] [Related]
8. The role of carcinoembryonic antigen as a predictor of the need for preoperative computed tomography in colon cancer patients.
Holt AD; Kim JT; Murrell Z; Huynh R; Stamos MJ; Kumar RR
Am Surg; 2006 Oct; 72(10):897-901. PubMed ID: 17058730
[TBL] [Abstract][Full Text] [Related]
9. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
Bakalakos EA; Burak WE; Young DC; Martin EW
Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
[TBL] [Abstract][Full Text] [Related]
10. Prospective monitoring trial for carcinoma of colon and rectum after surgical resection.
Wanebo HJ; Llaneras M; Martin T; Kaiser D
Surg Gynecol Obstet; 1989 Dec; 169(6):479-87. PubMed ID: 2683153
[TBL] [Abstract][Full Text] [Related]
11. Elevated carcinoembryonic antigen and sarcoidosis masquerading as metastatic colon cancer.
Gallagher DJ; Libby DM; Kemeny N
Clin Colorectal Cancer; 2009 Jul; 8(3):172-4. PubMed ID: 19632934
[TBL] [Abstract][Full Text] [Related]
12. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
Metser U; You J; McSweeney S; Freeman M; Hendler A
AJR Am J Roentgenol; 2010 Mar; 194(3):766-71. PubMed ID: 20173157
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer.
Wood CB; Ratcliffe JG; Burt RW; Malcolm AJ; Blumgart LH
Br J Surg; 1980 Jan; 67(1):46-8. PubMed ID: 7357243
[TBL] [Abstract][Full Text] [Related]
14. Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence.
Freeny PC; Marks WM; Ryan JA; Bolen JW
Radiology; 1986 Feb; 158(2):347-53. PubMed ID: 3941861
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of patients with colorectal cancer.
Deveney KE; Way LW
Am J Surg; 1984 Dec; 148(6):717-22. PubMed ID: 6507742
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoguided surgery in recurrent colorectal cancer: the role of carcinoembryonic antigen, computerized tomography, and physical examination.
Sardi A; Agnone CM; Nieroda CA; Mojzisik C; Hinkle G; Ferrara P; Farrar WB; Bolton J; Thurston MO; Martin EW
South Med J; 1989 Oct; 82(10):1235-44. PubMed ID: 2799440
[TBL] [Abstract][Full Text] [Related]
17. Results of CEA-initiated second-look surgery for recurrent colorectal cancer.
Steele G; Zamcheck N; Wilson R; Mayer R; Lokich J; Rau P; Maltz J
Am J Surg; 1980 Apr; 139(4):544-8. PubMed ID: 7369462
[No Abstract] [Full Text] [Related]
18. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer.
Wanebo JH; Stearns M; Schwartz MK
Ann Surg; 1978 Oct; 188(4):481-93. PubMed ID: 697433
[TBL] [Abstract][Full Text] [Related]
19. FDG-PET positive granuloma of the liver mimicking local recurrence after hepatic resection of colorectal liver metastasis.
Donadon M; Bona S; Montorsi M; Torzilli G
Hepatogastroenterology; 2010; 57(97):138-9. PubMed ID: 20422889
[TBL] [Abstract][Full Text] [Related]
20. PET/CT: will it change the way that we use CT in cancer imaging?
Hicks RJ; Ware RE; Lau EW
Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
